Tequesta to vote Thursday on drug treatment center

Tequesta to vote Thursday on drug treatment center
Tequesta to vote Thursday on drug treatment center
Read more on The Palm Beach Post

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA
Covidien, a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for its Fentanyl Transdermal System (FTS) patch. Covidien is the largest supplier of controlled pain medications in the United States based on number of prescriptions.
Read more on News-Medical-Net

National Agenda
USF’s most prominent alumnus returns to campus to share his perspective as drug czar.
Read more on University of South Florida